Invasive Aspergillosis Recruiting Phase 3 Trials for Anidulafungin (DB00362)

IndicationStatusPhase
DBCOND0031838 (Invasive Aspergillosis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04876716Azole-echinocandin Combination Therapy for Invasive AspergillosisTreatment